Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology.

E Akalin1, R C Hendrix, R G Polavarapu

  • 1Renal Division, Department of Medicine, Transplantation Section, Emory University, Atlanta, Georgia, USA.

Transplantation
|September 26, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for developing upper limb cellulitis after breast cancer treatment.

Lymphology·2022
Same author

Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide.

CellR4-- repair, replacement, regeneration, & reprogramming·2019
Same author

Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

Clinicopathologic Features of Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits.

Kidney international reports·2017
Same author

Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

High-density oligoarray technology identified novel gene expression patterns in human renal allograft rejection. This method offers new insights into rejection mechanisms and diagnosis without prior gene knowledge.

Area of Science:

  • Nephrology
  • Immunology
  • Genomics

Background:

  • Human renal allograft rejection is a significant clinical challenge.
  • Gene expression profiling offers a novel approach to understanding rejection.
  • Previous studies have not utilized high-density oligoarrays for this purpose.

Purpose of the Study:

  • To investigate gene expression profiles in human renal allograft rejection using high-density oligoarray technology.
  • To identify genes consistently up-regulated or down-regulated during acute cellular rejection.

Main Methods:

  • Analysis of 6800 human genes using high-density oligoarrays (GeneChip, Affymetrix).
  • Comparison of gene expression between seven acute rejection and three control renal allograft biopsies.
  • Definition of significant up-regulation as a fourfold or greater increase in transcript abundance.

Related Experiment Videos

Main Results:

  • Between 32 and 219 gene transcripts were up-regulated (>fourfold) during acute rejection.
  • Four genes (human monokine induced by interferon-gamma, T-cell receptor active beta-chain protein, interleukin-2 stimulated phosphoprotein, and RING4) were consistently up-regulated.
  • Unexpectedly, significant up-regulation of known cytotoxic T-cell effector molecules was not detected.

Conclusions:

  • High-density oligoarray technology is effective for screening gene expression in transplanted tissues during rejection.
  • This unbiased approach can reveal novel insights into the mechanisms and diagnosis of renal allograft rejection.